B6.Cg-Tg(ITGAM-cre)2781Gkl/Flmg

Status

Available to order

EMMA IDEM:04788
International strain nameB6.Cg-Tg(ITGAM-cre)2781Gkl/Flmg
Alternative nameCD11b-Cre
Strain typeTransgenic Strains
Allele/Transgene symbolTg(ITGAM-cre)2781Gkl
Gene/Transgene symbolTg(ITGAM-cre)2781Gkl

Information from provider

ProviderGeorge Kollias
Provider affiliationB.S.R.C.
Genetic informationFor the generation of CD11b-Cre transgenic mice, a 1.7kb DNA fragment (position -1584kb - +85bp) of the human ITGAM (CD11b) promoter (Hickstein et al., 1992) was cloned by amplification, from genomic DNA derived from the human leukemic myelomonocytic cell line U937. Sense primer: 5'-CGGGGTACCGGTTCAAAGTGATTCTGC-3' introduced a KpnI restriction site, antisense primer: 5'-CCGCTCGAGTGGAAGGAGCCAGAACC-3' created a XhoI restriction site at position + 85bp of the promoter. The KpnI-XhoI fragment was cloned to respective restriction sites of the pBluescript (Stratagene) vector containing the cre recombinase gene. As a polyadenylation signal, the human growth hormone (2.2Kb) gene was used. The transgene was isolated for microinjection into fertilized eggs as a KpnI-NotI fragment.
Phenotypic informationNo abnormal phenotype detected. This strain expresses cre recombinase under the human ITGAM (CD11b) promoter. When crossed with a strain containing a loxP site-flanked sequence of interest, cre mediated recombination results in deletion of the targeted sequence specifically in peritoneal macrophages and microglial cells. This strain represents an effective tool for the generation of cell specific targeted mutants.
References
  • Onset and progression in inherited ALS determined by motor neurons and microglia.;Boillée Séverine, Yamanaka Koji, Lobsiger Christian S, Copeland Neal G, Jenkins Nancy A, Kassiotis George, Kollias George, Cleveland Don W, ;2006;Science (New York, N.Y.);312;1389-92; 16741123

Information from EMMA

Archiving centreB.S.R.C. Alexander Fleming, Vari, Greece
Animals used for archivingheterozygous C57BL/6J, wild-type C57BL/6J
Stage of embryosMorula

Literature references

  • Onset and progression in inherited ALS determined by motor neurons and microglia.;Boillée Séverine, Yamanaka Koji, Lobsiger Christian S, Copeland Neal G, Jenkins Nancy A, Kassiotis George, Kollias George, Cleveland Don W, ;2006;Science (New York, N.Y.);312;1389-92; 16741123
  • Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.;Cheng Jinbo, Liao Yajin, Dong Yuan, Hu Han, Yang Nannan, Kong Xiangxi, Li Shuoshuo, Li Xiaoheng, Guo Jifeng, Qin Lixia, Yu Jiezhong, Ma Cungen, Li Jianke, Li Mingtao, Tang Beisha, Yuan Zengqiang, ;2020;Autophagy;16;2193-2205; 32003282

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).